Opsismodysplasia a Report of Two Cases

Total Page:16

File Type:pdf, Size:1020Kb

Opsismodysplasia a Report of Two Cases MOZGÁSSZERVI DIAGNOSZTIKA Esetismertetés Opsismodysplasia A report of two cases Al Kaissi A, Chehida FB, Nessib N, Ghachem MB, Kozlowski K Opsismodysplasia – Két eset ismertetése INTRODUCTION – Opsismodysplasia is a rare, severe, neona- BEVEZETÉS – Az opsismodysplasia ritka, újszülöttkori tör- tal dwarfism usually associated with fatal outcome in the first peség, amely általában fatális kimenetelû az élet elsô évé- few years of life. Up to, 2003 about 15 cases have been report- ben. 2003-ig összesen 15 esetrôl számoltak be az irodalom- ed. ban. CASE REPORT – We describe two brothers six and four years ESETTANULMÁNY – Egy hat- és négyéves testvérpár op- old with opsismodysplasia, who presented to the paediatric sismodysplasia esetét mutatjuk be. Alacsony növés és genu orthopaedic clinic with the diagnosis of short stature and genu varum deformitás miatt vizsgálták ôket a gyermekortopédiai varum deformity. rendelésen. CONCLUSION – Paediatric specialists should be aware, that KÖVETKEZTETÉS – A gyermekspecialisták az egészségügyi in rare instances, with improving medical care, they may see ellátás javulásával ritkán, de találkozhatnak olyan súlyos children with severe bone dysplasias which usually do not reach csontdysplasiában szenvedô gyermekekkel, akik nem érik el age in which paediatric orthopaedic services are required. azt a kort, amikor gyermekortopédiai ellátás szükséges. spondyloepimetaphyseal dysplasia, platyspondyly, spondyloepimetaphysealis dysplasia, platyspondylia, retarded bone age, acromelic dysplasia retardált csontkor AL KAISSI A, NESSIB N, GHACHEM MB: Service d'Orthopedie Infantile; CHEHIDA FB: Service de Radiologie Pediatrique, Hopi- tal d'Enfants, Tunis, Tunesie KOZLOWSKI K (corresponding author): Department of Medical Imaging, New Children's Hospital; Locked Bag 4001, West- mead NSW 2145, Australia. Phone/fax: (02) 9438-2562. E-mail: [email protected] 76 Érkezett: 2003. december 11. Elfogadva: 2004. január 5. psismodysplasia is a rare bone dysplasia delivery. The baby was very inactive during the usually with fatal outcome in the first few pregnancy. At birth he was 44 cm long, weighed O years of life1–8. The oldest recorded patient 2600 g, and had OFC 35.5 cm. At the age of 4 years of Maroteaux et al was 4 year and 8 month old2 and his height was 70 cm, upper segment/lower seg- that of Taybi and Lachman 5 year and 6 month old5. ment 41 cm/29 cm, weight 14 kg. The phenotypic Although the phenotype of opsismodysplasia is appearances and physical examination were similar characteristic, it is the radiographic examination to that of his brother. The only significant differ- which is decisive for the diagnosis. The diagnostic ences were opened fontanels and less severe genu features include extreme platyspondyly, markedly varum deformity. His mental development was retarded epiphyseal and carpal bone age, and normal. unique appearances of the pelvis, short tubular bones and calcaneus. Laboratory examinations C ASES REPORT The laboratory tests in both patients including rou- tine blood and urine examinations, urinary screen- Patient I. ing for mucopolysaccharides, aminoacids, organic acids, serum calcium, phosphorus and alkaline The propositus was born at 39 weeks gestation to phosphatase – were all normal. The karyotypes a G2P2 mother. The pregnancy was complicated by were normal. vaginal bleeding in the first part of pregnancy. The baby was very inactive during the pregnancy. At birth, the mother was 28 and the father 37 year- Radiographic examination old. An older sibling is normal. At birth he was 42 cm long, weighted 2430 g and had an OFC Radiographic examination documented identical 36 cm. changes in both the brothers, the differences being He presented at the Paediatric Orthopaedic Cli- only those of age (Figs. 1–5.). The changes were nic at 6 year because of short stature, bowed legs and waddling gait. His height was 75 cm, upper segment/lower segment 41 cm/34 cm, weight 19 kg, OFC 51 cm. His cranium was large in relation to the face. There was a prominent forehead, hypertelorism, depressed nasal root, anteverted nostrils, and long philtrum. The upper part of the auricle was large, deviated outwards and the helix pattern was abnor- mal. There was shortening of the extremities, the hands and feet being most severely affected. There was hypotonia with decrease in joint mobility and there was severe genus varum deformity. The chest was bell shaped and concave in the A-P diameter. The abdomen was protruding. The heart and abdominal ultrasound were all normal. His mental development was normal and he was doing well at school. Patient II. Fig. 1. Photograph of the two patients (6 ½ and 4 year-old). Micromelic dwarfism with disproportion- Younger brother of Patient I presented because of ately short hands and feet. Prominent forehead. Hyper- short stature and waddling gait at 4 years of age. telorism. Saddle nose. Long philtrum. Small chin. Bowed He was born following a normal pregnancy and legs M AGYAR R ADIOLÓGIA 2004;78(2):76–80. 77 a b c Fig. 2. Patient I. 1 ½ year-old. a) Flattened, anteriorly pointed vertebral bod- ies. b) Large anterior and posterior fontanels c) The ilia have a peculiar shape resembling Echidna (anteater). The acetabular roof – horizontal and concave – appear like the feet of the animal and the sacro-iliac part corresponds to its head. The femoral necks are broad and short. The pubic and ischial bones are well ossified a b c Fig. 3. Patient I. 5 year-old. a) Little change in comparison with fig. 2. a). Hyperlordosis. Horizontal position of the sacrum. b) Little change in comparison with fig. 2. c) beside of enlargement of the proximal end of the femora. c) The leg bones are short and bowed. Absence of knee ossification centers. The knee metaphyses are wide with medi- al elongation those of severe spondyloepimetaphyseal dysplasia. were disproportionally affected. They showed high- The diagnostic features included: extreme platys- ly unusual configuration. The proximal ends of the pondyly, widened metaphyses and markedly de- metacarpals were slightly pointed and the meta- layed epiphyseal and carpal bone age. The fontanels physes were cup shaped. The phalanges were pawn were closed in the older sibling but they were still shaped but the 2nd-4th middle phalanges were opened in the younger brother. All the tubular slightly angel shaped. bones were shortened. The short tubular bones We would like to stress two further distinctive 78 Al Kaissi A: Opsismodysplasia a b c Fig. 4. Patient I. 6 ½ year-old. a) Excessively short tubular bones. The proxi- mal ends of the metacarpals are pointed and irregularly ossified. The distal d ends are cupped. The phalanges are pawn shaped and the 2nd-4th proximal phalanges are slighly angel shaped. Only two small carpal ossification centers are present. b) Hypoplastic/dysplastic short tubular and tarsal bones. Only 5 tarsal ossification centers are demonstrated c) A spur is present at the lateral aspect of the 1st metatarsal and 2 spurs are at the lower aspect of the calca- neus. d) MR shows hypoplastic dens of C2 and unossified posterior arch of C1 abnormalities not yet reported but documented in poses to respiratory infections4, and hypoplastic our siblings. In the feet, the 1st metatarsal presen- dens with increased C1/C2 mobility may cause ted with a medial spur and the calcaneus showed sudden respiratory death. The radiographic abnor- two spurs at the lowest aspect. In the pelvis, the malities are unique and the diagnostic difficulties shape of the iliac bones resembled echidna in full born infants may arise only if the investiga- (anteater). We do not know at what age the dis- tor is unfamiliar with the disorder. Slightly resem- tinctive features of the 1st metacarpal, the calca- bling opsismodysplasia are achondrogenesis syn- neus and the pelvis appear as the radiographic do- dromes such as achondrogenesis I, II, hypochon- cumentation of older patients with opsismodyspla- drogenesis and bone dysplasias with severe sia is inadequate. MR of the suboccipital region in platyspondyly such as platyspondylic dwarfism the first patient at the age of 6 year 6 month docu- – Torrance type4. Achondrogenesis syndromes die mented unossified, hypoplastic dens and unossi- soon after the birth. Platyspondylic dwarfism – Tor- fied posterior arch of C1. rance type – does not have such severe shortening of stature, and has different appearances of the hands, feet, pelvis and calcaneus. Exceptionally D ISCUSSION delayed bone age is another distinguishing feature of opsismodysplasia. Diagnostic difficulties may Children with opsismodysplasia succumb usually arise in aborted foetuses particularly those below in the first few years of life due to respiratory com- 16-18 weeks gestation. Abnormal histology is char- plications. Persistent muscular hypotonia predis- acterised by irregular, partly hypertrophied carti- M AGYAR R ADIOLÓGIA 2004;78(2):76–80 79 a b c Fig. 5. Patient II. 3 year-old. a) Echidna shape of the iliac bones is well demonstrated in this patient. b) Slightly bowed leg bones. Widened metaphyses with slight medial elongation. c) Proximal short- ening of radius and distal shortening of ulna. Widening of the ends of the tubular bones. Markedly retarded bone age lage, decreased connective tissue and short irregu- positive with type I collagen antibody2. Familial lar trabeculae might be helpful in these circum- occurrence of opsismodysplasia in two sibs sup- stances. Immunohistochemical staining is highly ports autosomal recessive inheritance. References 1. Beemer F, Kozlowski K. Additional case of opsismodysplasia orders, and skeletal dysplasias. 4th Ed. St. Louis: Mosby-Year supporting autosomal recessive inheritance. Am J Med Genet Book; 1996. p. 872-4. 1994;49:344-7. 6. Tyler K, Sarioglu N, Kunze J. Five familial cases of opsis- 2. Maroteaux P, Stanescu V, Stanescu R, Le Marec B, Moraine modysplasia substantiate the hypothesis of autosomal reces- C, Lejarraga H. Am J Med Genet 1984;19:171-82. sive inheritance. Am J Med Genet 1999;83:47-52. 3. Santos HG, Saraiva. Opsismodysplasia: another case and lit- 7.
Recommended publications
  • Clinical, Radiological, and Chondro
    195 LETTER TO JMG J Med Genet: first published as 10.1136/jmg.40.3.195 on 1 March 2003. Downloaded from Clinical, radiological, and chondro-osseous findings in opsismodysplasia: survey of a series of 12 unreported cases V Cormier-Daire, A L Delezoide, N Philip, P Marcorelles, K Casas, Y Hillion, L Faivre, D L Rimoin, A Munnich, P Maroteaux, M Le Merrer ............................................................................................................................. J Med Genet 2003;40:195–200 psismodysplasia (opsismos in Greek = late) is a rare Key points chondrodysplasia, first described in 1977 by Zonana et al1 as a unique chondrodysplasia and designated O 2 “opsismodysplasia” only in 1984. The disorder is character- • We present the clinical, radiographic, and histological ised clinically by micromelia with extremely short hands and findings of 11 new cases of opsismodysplasia feet and respiratory distress responsible for death in the first belonging to eight families. few years of life.2 The main radiological features include severe • All cases presented with dysmorphic features, large platyspondyly, major delay in skeletal ossification, and anterior fontanelle, short hands and feet, and short stat- metaphyseal cupping. To date, 13 cases have been reported ure. Radiographic features included very delayed bone and recurrence in sibs and/or consanguinity have suggested maturation, marked shortness of the hand and foot an autosomal recessive mode of inheritance.1–6 Here, we bones with metaphyseal cupping and thin vertebral describe the clinical, radiological and chondro-osseous find- bodies. ings of 12 previously unreported cases in nine families. We • The outcome was variable and five children are still show that opsismodysplasia is not a consistently lethal condi- alive.
    [Show full text]
  • Mackenzie's Mission Gene & Condition List
    Mackenzie’s Mission Gene & Condition List What conditions are being screened for in Mackenzie’s Mission? Genetic carrier screening offered through this research study has been carefully developed. It is focused on providing people with information about their chance of having children with a severe genetic condition occurring in childhood. The screening is designed to provide genetic information that is relevant and useful, and to minimise uncertain and unclear information. How the conditions and genes are selected The Mackenzie’s Mission reproductive genetic carrier screen currently includes approximately 1300 genes which are associated with about 750 conditions. The reason there are fewer conditions than genes is that some genetic conditions can be caused by changes in more than one gene. The gene list is reviewed regularly. To select the conditions and genes to be screened, a committee comprised of experts in genetics and screening was established including: clinical geneticists, genetic scientists, a genetic pathologist, genetic counsellors, an ethicist and a parent of a child with a genetic condition. The following criteria were developed and are used to select the genes to be included: • Screening the gene is technically possible using currently available technology • The gene is known to cause a genetic condition • The condition affects people in childhood • The condition has a serious impact on a person’s quality of life and/or is life-limiting o For many of the conditions there is no treatment or the treatment is very burdensome for the child and their family. For some conditions very early diagnosis and treatment can make a difference for the child.
    [Show full text]
  • Rapid Publication International Nosology and Classification of Constitutional Disorders of Bone
    American Journal of Medical Genetics 113:65–77 (2002) Rapid Publication International Nosology and Classification of Constitutional Disorders of Bone (2001) Christine M. Hall* Department of Radiology, Great Ormond Street Children’s Hospital, London, United Kingdom The last International Classification of Con- combination of morphological and molecular groupings stitutional Disorders of Bone was published it is anticipated that two parallel but interacting clas- in 1998. Since then rapid advances have been sifications will evolve: one clinical, identifying accepted made in identifying the molecular changes terminology or nosology, and the other molecular, to responsible for defined conditions and new help further understand the pathogenesis of individual disorders are constantly being delineated. disorders. For these reasons a further update on the The major change in the classification has been the classification is appropriate. It has been addition of genetically determined dysostoses to the expended to not only the osteochondrodys- skeletal dysplasias or osteochondrodysplasias. This is plasias (33 groups) but also genetically deter- because in clinical practice these two groups overlap. mined dysostoses (3 groups). Dysostoses may be defined as skeletal malformations ß 2002 Wiley-Liss, Inc. occurring singly or in combination. The dysostoses are static and their malformations occur during blastogen- KEY WORDS: osteochondrodysplasia; dys- esis (the first eight weeks of embryonic life). This is in ostosis; gene contrast to the skeletal dysplasias which often present after this stage, have a more general skeletal involve- ment and continue to evolve as a result of active gene The International Working Group on the Classifica- involvement throughout life. Only those dysostoses tion of Constitutional Disorders of Bone met in Oxford which have an identified chromosomal locus have been on September 4th and 5th 2001 to update the last clas- included.
    [Show full text]
  • Blueprint Genetics Comprehensive Skeletal Dysplasias and Disorders
    Comprehensive Skeletal Dysplasias and Disorders Panel Test code: MA3301 Is a 251 gene panel that includes assessment of non-coding variants. Is ideal for patients with a clinical suspicion of disorders involving the skeletal system. About Comprehensive Skeletal Dysplasias and Disorders This panel covers a broad spectrum of skeletal disorders including common and rare skeletal dysplasias (eg. achondroplasia, COL2A1 related dysplasias, diastrophic dysplasia, various types of spondylo-metaphyseal dysplasias), various ciliopathies with skeletal involvement (eg. short rib-polydactylies, asphyxiating thoracic dysplasia dysplasias and Ellis-van Creveld syndrome), various subtypes of osteogenesis imperfecta, campomelic dysplasia, slender bone dysplasias, dysplasias with multiple joint dislocations, chondrodysplasia punctata group of disorders, neonatal osteosclerotic dysplasias, osteopetrosis and related disorders, abnormal mineralization group of disorders (eg hypopohosphatasia), osteolysis group of disorders, disorders with disorganized development of skeletal components, overgrowth syndromes with skeletal involvement, craniosynostosis syndromes, dysostoses with predominant craniofacial involvement, dysostoses with predominant vertebral involvement, patellar dysostoses, brachydactylies, some disorders with limb hypoplasia-reduction defects, ectrodactyly with and without other manifestations, polydactyly-syndactyly-triphalangism group of disorders, and disorders with defects in joint formation and synostoses. Availability 4 weeks Gene Set Description
    [Show full text]
  • Discover Dysplasias Gene Panel
    Discover Dysplasias Gene Panel Discover Dysplasias tests 109 genes associated with skeletal dysplasias. This list is gathered from various sources, is not designed to be comprehensive, and is provided for reference only. This list is not medical advice and should not be used to make any diagnosis. Refer to lab reports in connection with potential diagnoses. Some genes below may also be associated with non-skeletal dysplasia disorders; those non-skeletal dysplasia disorders are not included on this list. Skeletal Disorders Tested Gene Condition(s) Inheritance ACP5 Spondyloenchondrodysplasia with immune dysregulation (SED) AR ADAMTS10 Weill-Marchesani syndrome (WMS) AR AGPS Rhizomelic chondrodysplasia punctata type 3 (RCDP) AR ALPL Hypophosphatasia AD/AR ANKH Craniometaphyseal dysplasia (CMD) AD Mucopolysaccharidosis type VI (MPS VI), also known as Maroteaux-Lamy ARSB syndrome AR ARSE Chondrodysplasia punctata XLR Spondyloepimetaphyseal dysplasia with joint laxity type 1 (SEMDJL1) B3GALT6 Ehlers-Danlos syndrome progeroid type 2 (EDSP2) AR Multiple joint dislocations, short stature and craniofacial dysmorphism with B3GAT3 or without congenital heart defects (JDSCD) AR Spondyloepimetaphyseal dysplasia (SEMD) Thoracic aortic aneurysm and dissection (TADD), with or without additional BGN features, also known as Meester-Loeys syndrome XL Short stature, facial dysmorphism, and skeletal anomalies with or without BMP2 cardiac anomalies AD Acromesomelic dysplasia AR Brachydactyly type A2 AD BMPR1B Brachydactyly type A1 AD Desbuquois dysplasia CANT1 Multiple epiphyseal dysplasia (MED) AR CDC45 Meier-Gorlin syndrome AR This list is gathered from various sources, is not designed to be comprehensive, and is provided for reference only. This list is not medical advice and should not be used to make any diagnosis.
    [Show full text]
  • Whole Exome Sequencing Gene Package Skeletal Dysplasia, Version 2.1, 31-1-2020
    Whole Exome Sequencing Gene package Skeletal Dysplasia, Version 2.1, 31-1-2020 Technical information DNA was enriched using Agilent SureSelect DNA + SureSelect OneSeq 300kb CNV Backbone + Human All Exon V7 capture and paired-end sequenced on the Illumina platform (outsourced). The aim is to obtain 10 Giga base pairs per exome with a mapped fraction of 0.99. The average coverage of the exome is ~50x. Duplicate and non-unique reads are excluded. Data are demultiplexed with bcl2fastq Conversion Software from Illumina. Reads are mapped to the genome using the BWA-MEM algorithm (reference: http://bio-bwa.sourceforge.net/). Variant detection is performed by the Genome Analysis Toolkit HaplotypeCaller (reference: http://www.broadinstitute.org/gatk/). The detected variants are filtered and annotated with Cartagenia software and classified with Alamut Visual. It is not excluded that pathogenic mutations are being missed using this technology. At this moment, there is not enough information about the sensitivity of this technique with respect to the detection of deletions and duplications of more than 5 nucleotides and of somatic mosaic mutations (all types of sequence changes). HGNC approved Phenotype description including OMIM phenotype ID(s) OMIM median depth % covered % covered % covered gene symbol gene ID >10x >20x >30x ABCC9 Atrial fibrillation, familial, 12, 614050 601439 65 100 100 95 Cardiomyopathy, dilated, 1O, 608569 Hypertrichotic osteochondrodysplasia, 239850 ACAN Short stature and advanced bone age, with or without early-onset osteoarthritis
    [Show full text]
  • Skeletal Dysplasia Panel Versie V1 (345 Genen) Centrum Voor Medische Genetica Gent
    H9.1-OP2-B40: Genpanel Skeletal dysplasia, V1, in voege op 14/02/2020 Skeletal_dysplasia panel versie V1 (345 genen) Centrum voor Medische Genetica Gent Associated phenotype, OMIM phenotype ID, phenotype Gene OMIM gene ID mapping key and inheritance pattern Atrial fibrillation, familial, 12, 614050 (3), Autosomal dominant; ABCC9 601439 Cardiomyopathy, dilated, 1O, 608569 (3); Hypertrichotic osteochondrodysplasia, 239850 (3), Autosomal dominant Congenital heart defects and skeletal malformations syndrome, 617602 (3), Autosomal dominant; Leukemia, Philadelphia ABL1 189980 chromosome-positive, resistant to imatinib, 608232 (3), Somatic mutation Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans, 165800 (3), ACAN 155760 Autosomal dominant; Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3), Autosomal recessive; ?Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3), Autosomal dominant Spondyloenchondrodysplasia with immune dysregulation, 607944 ACP5 171640 (3), Autosomal recessive Fibrodysplasia ossificans progressiva, 135100 (3), Autosomal ACVR1 102576 dominant Weill-Marchesani syndrome 1, recessive, 277600 (3), Autosomal ADAMTS10 608990 recessive Weill-Marchesani 4 syndrome, recessive, 613195 (3), Autosomal ADAMTS17 607511 recessive ADAMTSL2 612277 Geleophysic dysplasia 1, 231050 (3), Autosomal recessive AFF4 604417 CHOPS syndrome, 616368 (3), Autosomal dominant AGA 613228 Aspartylglucosaminuria, 208400 (3), Autosomal recessive Rhizomelic chondrodysplasia punctata,
    [Show full text]
  • Utviklingsavvik V02
    2/1/2021 Utviklingsavvik v02 Avdeling for medisinsk genetikk Utviklingsavvik Genpanel, versjon v02 * Enkelte genomiske regioner har lav eller ingen sekvensdekning ved eksomsekvensering. Dette skyldes at de har stor likhet med andre områder i genomet, slik at spesifikk gjenkjennelse av disse områdene og påvisning av varianter i disse områdene, blir vanskelig og upålitelig. Disse genetiske regionene har vi identifisert ved å benytte USCS segmental duplication hvor områder større enn 1 kb og ≥90% likhet med andre regioner i genomet, gjenkjennes (https://genome.ucsc.edu). For noen gener ligger alle ekson i områder med segmentale duplikasjoner: ACTB, ACTG1, ASNS, ATAD3A, CA5A, CFC1, CLCNKB, CYCS, DDX11, GBA, GJA1, MSTO1, PIGC, RBM8A, RPL15, SBDS, SDHA, SHOX, SLC6A8 Vi gjør oppmerksom på at ved identifiseringav ekson oppstrøms for startkodon kan eksonnummereringen endres uten at transkript ID endres. Avdelingens websider har en full oversikt over områder som er affisert av segmentale duplikasjoner. ** Transkriptets kodende ekson. Ekson Gen Gen affisert (HGNC (HGNC Transkript Ekson** Fenotype av symbol) ID) segdup* AAAS 13666 NM_015665.6 1-16 Achalasia-addisonianism-alacrimia syndrome, 231550 AARS 20 NM_001605.2 2-21 Epileptic encephalopathy, early infantile, 29 616339 AARS2 21022 NM_020745.4 1-22 Combined oxidative phosphorylation deficiency 8, 614096 AASS 17366 NM_005763.4 2-24 Hyperlysinaemia (Disorders of histidine, tryptophan or lysine metabolism) ABAT 23 NM_020686.6 2-16 GABA transaminase deficiency (Disorders of neurotransmitter metabolism, gamma-aminobutyrate)
    [Show full text]
  • Opsismodysplasia: Phosphate Wasting Osteodystrophy Responds to Bisphosphonate Therapy
    CLINICAL CASE STUDY published: 22 June 2015 doi: 10.3389/fped.2015.00048 Opsismodysplasia: phosphate wasting osteodystrophy responds to bisphosphonate therapy Ansab Khwaja1, Shawn E. Parnell2, Kathryn Ness3, Viviana Bompadre1 and Klane K. White1* 1 Orthopedics and Sports Medicine, Seattle Children’s Hospital, University of Washington, Seattle, WA, USA, 2 Department of Radiology, Seattle Children’s Hospital, University of Washington, Seattle, WA, USA, 3 Division of Endocrinology, Department of Pediatrics, Seattle Children’s Hospital, University of Washington, Seattle, WA, USA We present two siblings affected with opsismodysplasia (OPS), a rare skeletal dysplasia caused by mutations in the inositol polyphosphate phosphatase-like 1 gene. The skeletal findings include short stature with postnatal onset micromelia, marked platyspondyly, squared metacarpals, delayed skeletal ossification, metaphyseal cupping, and postnatal micromelia. Respiratory compromise, delayed ambulation, and progressive lower extremity deformities are described. The severity of findings is variable. Renal phosphate wasting Edited by: Jeff Martus, is associated with severe bone demineralization and a more severe phenotype. This Vanderbilt Children’s Hospital, USA report represents the first described cases of opsismodysplasia treated with intravenous Reviewed by: bisphosphonate (pamidronate). Surgical management for lower extremity deformities Jason Troy Rhodes, University of Colorado, USA associated with OPS is also reviewed. Ryan D. Muchow, Level of Evidence: IV Case series University of Kentucky, USA Christine Ann Ho, Keywords: opsismodysplasia, metabolic bone disease, skeletal dysplasias, scoliosis, genu varum, bisphosphonates Texas Scottish Rite Hospital, USA *Correspondence: Klane K. White, Orthopedics and Sports Medicine, Introduction Seattle Children’s Hospital, University of Washington, 4800 Sand Point Opsismodysplasia (OPS) is a rare autosomal recessive skeletal dysplasia associated with delayed Way, OA.9.120, Seattle, WA, USA bone maturation and micromelia (1, 2).
    [Show full text]
  • Skeletal Dysplasia Panel Versie V2 (346 Genen) Centrum Voor Medische Genetica Gent
    H9.1-OP2-B40: Genpanel Skeletal dysplasia, V2, in voege op 26/05/2020 Skeletal_dysplasia panel versie V2 (346 genen) Centrum voor Medische Genetica Gent Associated phenotype, OMIM phenotype ID, phenotype Gene OMIM gene ID mapping key and inheritance pattern Atrial fibrillation, familial, 12, 614050 (3), Autosomal dominant; ABCC9 601439 Cardiomyopathy, dilated, 1O, 608569 (3); Hypertrichotic osteochondrodysplasia, 239850 (3), Autosomal dominant Congenital heart defects and skeletal malformations syndrome, 617602 (3), Autosomal dominant; Leukemia, Philadelphia ABL1 189980 chromosome-positive, resistant to imatinib, 608232 (3), Somatic mutation Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans, 165800 (3), ACAN 155760 Autosomal dominant; Spondyloepimetaphyseal dysplasia, aggrecan type, 612813 (3), Autosomal recessive; ?Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3), Autosomal dominant Spondyloenchondrodysplasia with immune dysregulation, 607944 (3), ACP5 171640 Autosomal recessive ACVR1 102576 Fibrodysplasia ossificans progressiva, 135100 (3), Autosomal dominant Weill-Marchesani syndrome 1, recessive, 277600 (3), Autosomal ADAMTS10 608990 recessive Weill-Marchesani 4 syndrome, recessive, 613195 (3), Autosomal ADAMTS17 607511 recessive ADAMTSL2 612277 Geleophysic dysplasia 1, 231050 (3), Autosomal recessive AFF4 604417 CHOPS syndrome, 616368 (3), Autosomal dominant AGA 613228 Aspartylglucosaminuria, 208400 (3), Autosomal recessive Rhizomelic chondrodysplasia punctata,
    [Show full text]
  • Bilateral Hereditary Micro-Epiphyseal Dysplasia – Clinical and Genetic Analysis of a Dutch Family
    BILATERAL HEREDITARY MICRO-EPIPHYSEAL DYSPLASIA Clinical and genetic analysis of a Dutch family Bilaterale hereditaire micro-epifysaire dysplasie Klinisch en genetisch onderzoek van een Nederlandse familie (met een samenvatting in het Nederlands) ADRIANUS KLAZINUS MOSTERT Cover design: The author Copy-editing/lay-out: Thea Schenk Printed by: PrintPartners Ipskamp BV, Enschede. © A.K. Mostert, Zwolle, 2003 All rights reserved. No part of this book may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of the holder of the copyright. Mostert, A.K. Bilateral hereditary micro-epiphyseal dysplasia – Clinical and genetic analysis of a Dutch family. Thesis University of Utrecht, with summary in Dutch. ISBN: 90-9016417-0 ii BILATERAL HEREDITARY MICRO-EPIPHYSEAL DYSPLASIA Clinical and genetic analysis of a Dutch family Bilaterale hereditaire micro-epifysaire dysplasie Klinisch en genetisch onderzoek van een Nederlandse familie (met een samenvatting in het Nederlands) PROEFSCHRIFT Ter verkrijging van de graad van doctor aan de Universiteit Utrecht op gezag van de Rector Magnificus, Prof. dr. W.H. Gispen, ingevolge het besluit van het College voor Promoties in het openbaar te verdedigen op maandag 22 september 2003 des middags te 14.30 uur door ADRIANUS KLAZINUS MOSTERT geboren op 30 april 1962 te Winschoten Promotores: Prof. Dr. D. Lindhout, kinderarts-geneticus Prof. Dr. J.R. van Horn, orthopaedisch chirurg Copromotores: Dr. B.R.H. Jansen, orthopaedisch chirurg Prof. Dr. P. Heutink, moleculair geneticus iv Like apples of gold in settings of silver, so is a word spoken at the right moment.
    [Show full text]
  • Skeletal Dysplasia Panel Versie V3 (450 Genen) Centrum Voor Medische Genetica Gent
    H9.1-OP2-B40: Genpanel Skeletal dysplasia, in voege op 02/06/2021 Skeletal_dysplasia panel versie v3 (450 genen) Centrum voor Medische Genetica Gent Associated phenotype, OMIM phenotype ID, phenotype Gene OMIM gene ID mapping key and inheritance pattern Hypertrichotic osteochondrodysplasia, 239850 (3), Autosomal dominant; ?Atrial fibrillation, familial, 12, 614050 (3), ABCC9 601439 Autosomal dominant; Cardiomyopathy, dilated, 1O, 608569 (3), Autosomal dominant Leukemia, Philadelphia chromosome-positive, resistant to imatinib, 608232 (3), Somatic mutation; Congenital heart ABL1 189980 defects and skeletal malformations syndrome, 617602 (3), Autosomal dominant Short stature and advanced bone age, with or without early- onset osteoarthritis and/or osteochondritis dissecans, 165800 (3), Autosomal dominant; Spondyloepimetaphyseal dysplasia, ACAN 155760 aggrecan type, 612813 (3), Autosomal recessive; ?Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3), Autosomal dominant Spondyloenchondrodysplasia with immune dysregulation, ACP5 171640 607944 (3), Autosomal recessive Fibrodysplasia ossificans progressiva, 135100 (3), Autosomal ACVR1 102576 dominant Weill-Marchesani syndrome 1, recessive, 277600 (3), ADAMTS10 608990 Autosomal recessive Weill-Marchesani 4 syndrome, recessive, 613195 (3), ADAMTS17 607511 Autosomal recessive ADAMTSL2 612277 Geleophysic dysplasia 1, 231050 (3), Autosomal recessive AFF4 604417 CHOPS syndrome, 616368 (3), Autosomal dominant AGA 613228 Aspartylglucosaminuria, 208400 (3), Autosomal recessive Rhizomelic chondrodysplasia
    [Show full text]